These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23158747)

  • 1. [Status of joint and intracranial bleeding of moderate and severe hemophilia in children under on-demand therapy].
    He WW; Wu RH
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):636-8. PubMed ID: 23158747
    [No Abstract]   [Full Text] [Related]  

  • 2. Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data.
    Manners PJ; Price P; Buurman D; Lewin B; Smith B; Cole CH
    J Rheumatol; 2015 May; 42(5):885-90. PubMed ID: 25729030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between factor VIII replacement therapy and joint damage in severe haemophilia.
    Lowe GD
    Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S3-5. PubMed ID: 9351528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis therapy in haemophilia A: current situation in Spain.
    Lucía JF; Aznar JA; Abad-Franch L; Escuin RR; Jiménez-Yuste V; Pérez R; Batlle J; Balda I; Alperovich G; Parra R;
    Haemophilia; 2011 Jan; 17(1):75-80. PubMed ID: 21070481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilia prophylaxis: a model and future directions in Jordan.
    Awidi A; Faouri S; Kiswani BA; Al-Sweedan S; Albarqawi M; Bsoul N; Haddadin I; Al-Falah M; Telfah A; Hermans C
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s343-4. PubMed ID: 24120588
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of joint bleeding in hemophilia.
    Simpson ML; Valentino LA
    Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy.
    Gregosiewicz A; Wośko I; Kandzierski G
    J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some aspects on the management of hemophilia.
    Aledort LM
    Thromb Haemost; 1995 Jul; 74(1):440-3. PubMed ID: 8578502
    [No Abstract]   [Full Text] [Related]  

  • 9. How I use bypassing therapy for prophylaxis in patients with hemophilia A and inhibitors.
    Leissinger CA; Singleton T; Kruse-Jarres R
    Blood; 2015 Jul; 126(2):153-9. PubMed ID: 25827834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-of-care ultronography can help detect subclinical hemarthrosis in hemophilic patients undergoing regular optimal clotting factor prophylaxis to achieve zero bleeding.
    Rodriguez-Merchan EC
    Expert Rev Hematol; 2023; 16(8):565-566. PubMed ID: 37289642
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
    Manco-Johnson MJ; Abshire TC; Shapiro AD; Riske B; Hacker MR; Kilcoyne R; Ingram JD; Manco-Johnson ML; Funk S; Jacobson L; Valentino LA; Hoots WK; Buchanan GR; DiMichele D; Recht M; Brown D; Leissinger C; Bleak S; Cohen A; Mathew P; Matsunaga A; Medeiros D; Nugent D; Thomas GA; Thompson AA; McRedmond K; Soucie JM; Austin H; Evatt BL
    N Engl J Med; 2007 Aug; 357(6):535-44. PubMed ID: 17687129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to target joint bleeding in hemophilia: prophylaxis for all or individualized treatment?
    Abshire T
    J Pediatr; 2004 Nov; 145(5):581-3. PubMed ID: 15520752
    [No Abstract]   [Full Text] [Related]  

  • 15. Including the life-time cumulative number of joint bleeds in the definition of primary prophylaxis.
    den Uijl IE; Fischer K
    Thromb Haemost; 2008 May; 99(5):965; author reply 966-8. PubMed ID: 18449430
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prevention of joint hemorrhages in Hemophilia A].
    van Creveld S; McEwan-Van der Horst ; Frese-Vorstelman DL
    Maandschr Kindergeneeskd; 1968 Dec; 36(8):253-9. PubMed ID: 5715995
    [No Abstract]   [Full Text] [Related]  

  • 17. Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A.
    Rossbach HC
    Vasc Health Risk Manag; 2010 Mar; 6():59-68. PubMed ID: 20234780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China.
    Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J
    Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term FEIBA prophylaxis does not prevent progression of existing joint disease.
    Hilgartner MW; Makipernaa A; Dimichele DM
    Haemophilia; 2003 May; 9(3):261-8. PubMed ID: 12694515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.